Eli Lilly played down risks of top drug: report
(Reute


Reuters - Drug giant Eli Lilly has engaged in a
decade-long effort to play down the health risks of its
top-selling medication, the schizophrenia drug Zyprexa, The New
York Times reported in Sunday editions.